SODIUM THIOSULFATE | N203923 | HOPE PHARMACEUTICALS
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Hope Medical Enterprises, Inc. v. Somerset Therapeutics, LLC et al 4 patentsANDA 220473Sodium Thiosulfate | D. Del. | 2025-12-17 | Active | — |
Hope Medical Enterprises, Inc. v. Accord Healthcare, Inc. 5 patentsANDA 217214Sodium Thiosulfate | D. Del. | 2025-07-10 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition From Hope Pharmaceuticals FDA-2014-P-0916 Hope Pharmaceuticals filed this citizen petition pursuant to sections 505(b) and 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA not approve any new applications for sodium nitrite and sodium thiosulfate drug products unless applicants meet or exceed the heightened purity | 505(q) | 2014-07-02 | Denied | Hope Pharmaceuticals |
Source: Regulations.gov. FDA citizen petitions matched by application number.